GLP-1 receptor agonists may not be suitable for individuals with a history of pancreatitis, kidney disease, or gallbladder issues
Floating specks, fibers, or crystals in the solution suggest contamination or precipitation
We recommend that all patients should be asked about glucagon-like peptide-1 receptor agonist (GLP-1RA) and dual GLP-1 and glucose-dependent insulinotropic polypeptide receptor co-agonist (GLP-1/GIPRA) use prior to anaesthesia or sedation for surgical and endoscopic procedures and be informed of the benefits and risks
We encourage patients to consult with our experienced healthcare providers to explore how Semaglutide GLP-1, alongside lifestyle changes, can be part of an effective strategy for achieving and maintaining a healthy weight
Single-use pens (Wegovy, Zepbound, Mounjaro) should be discarded after injection
Scientific Evidence: Research has shown that GLP-1 agonists can significantly improve insulin sensitivity and help regulate blood sugar
